SNX

150.43

-1.77%↓

SNX

150.43

-1.77%↓

SNX

150.43

-1.77%↓

SNX

150.43

-1.77%↓

SNX

150.43

-1.77%↓

Search

Nu Skin Enterprises Inc

Fermé

10.62 -0.19

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.47

Max

10.73

Chiffres clés

By Trading Economics

Revenu

-86M

21M

Ventes

22M

386M

P/E

Moyenne du Secteur

5.389

16.66

Rendement du dividende

2.18

Marge bénéficiaire

5.469

Employés

3,100

EBITDA

-109M

43M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.18%

8.33%

Prochains Résultats

6 nov. 2025

Date du Prochain Dividende

10 déc. 2025

Date du Prochain Détachement de Dividende

28 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

130M

542M

Ouverture précédente

10.81

Clôture précédente

10.62

Score Technique

By Trading Central

Confiance

Bearish Evidence

Nu Skin Enterprises Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 nov. 2025, 21:44 UTC

Résultats

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 nov. 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 nov. 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 nov. 2025, 23:28 UTC

Résultats

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 nov. 2025, 23:24 UTC

Résultats

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov. 2025, 23:14 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

3 nov. 2025, 23:14 UTC

Market Talk
Acquisitions, Fusions, Rachats

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 nov. 2025, 23:12 UTC

Résultats

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov. 2025, 23:09 UTC

Résultats

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 nov. 2025, 23:09 UTC

Résultats

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 nov. 2025, 23:09 UTC

Résultats

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 nov. 2025, 23:06 UTC

Market Talk
Résultats

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 nov. 2025, 22:36 UTC

Market Talk
Résultats

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 nov. 2025, 22:31 UTC

Résultats

Franco-Nevada 3Q EPS $1.49 >FNV

3 nov. 2025, 22:31 UTC

Résultats

Franco-Nevada 3Q Rev $487.7M >FNV

3 nov. 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 nov. 2025, 22:19 UTC

Acquisitions, Fusions, Rachats

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 nov. 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 nov. 2025, 21:54 UTC

Market Talk
Résultats

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 nov. 2025, 21:54 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

3 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 nov. 2025, 21:49 UTC

Résultats

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 nov. 2025, 21:40 UTC

Résultats

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 nov. 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 nov. 2025, 21:19 UTC

Résultats

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 nov. 2025, 21:11 UTC

Acquisitions, Fusions, Rachats

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 nov. 2025, 21:11 UTC

Résultats

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 nov. 2025, 21:07 UTC

Résultats

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 nov. 2025, 21:05 UTC

Résultats

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 nov. 2025, 21:05 UTC

Résultats

Palantir Technologies 3Q Net $475.6M >PLTR

Comparaison

Variation de prix

Nu Skin Enterprises Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

5.78 / 6.16Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Neutral Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
help-icon Live chat